Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tsc-204-C0702
Endocervical Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Tsc-204-C0702
Human Papillomavirus-Related Penile Squamous Cell Carcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Tsc-204-C0702
Vulvar Squamous Cell Carcinoma
TScan Therapeutics, Inc.
P1
CC
(41)
Tumor Antigen Loaded Autologous Dendritic Cells
Hepatocellular Carcinoma
West China Hospital
P1
CC
(41)
ucd7 cart
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P1
CC
(41)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes
Neutropenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
P1
CC
(41)
Wu-Cart-007
Anaplastic Large Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Angioimmunoblastic T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Extranodal Nasal NK/T Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Sezary Syndrome
Washington University School of Medicine
P1
CC
(41)
Wztl002-1
Diffuse Large B-Cell Lymphoma
Malaghan Institute of Medical Research
P1
CC
(41)
Wztl002-1
Mantle Cell Lymphoma
Malaghan Institute of Medical Research
P1
CC
(41)
yts104 cells
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
P1
CC
(41)
rd13-02 cell infusion
Neoplasm
Kai Lin Xu，MD
Early P1
CC
(41)
a2b395
Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b395
Colon Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b395
Lung Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b395
Renal Cell Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b395
Triple-Negative Breast Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b530
Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b530
Metastatic Malignant Neoplasm In The Colon
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b530
Non-Small Cell Lung Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b543
Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b543
Colon Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(41)
a2b543
Lung Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(41)
Showing 2051 to 2075 of 3,186 assets
Previous
Page 83 of 128
Next
